Literature DB >> 2569983

Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells.

B Capel1, B Mintz.   

Abstract

Neonatal unirradiated mice of W-mutant genotypes, with a hematopoietic stem cell defect and anemia, were injected i.v. with normal fetal liver hematopoietic cells. Efficient, long-term engraftment occurred as a result of the competitive advantage to the donor stem cells. The frequency of engraftment and rate of repopulation characteristically diminish in the series W/Wv, Wf/Wf, and Wv/+, in which the severity of the endogenous defect is progressively less. H-2 compatibility is required in the inbred strain combinations examined; other histocompatibility loci play a minor role in some strain combinations. Engraftment is due to self-renewing hematopoietic stem cells ancestral to myeloid and lymphoid lineages. The more mildly defective mutants display much greater variability in the kinetics of repopulation--a result consistent with seeding by single, or very few, stem cells that form developing clones. Engraftment efficiency is reduced by prolonged culture of fetal liver cells during experimental infection by recombinant retroviruses; nevertheless, after 24 h in vitro to achieve retroviral marking, stem cells retain their ability to repopulate and develop in W/Wv neonates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569983

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  2 in total

1.  CSF-1-induced Src signaling can instruct monocytic lineage choice.

Authors:  Max Endele; Dirk Loeffler; Konstantinos D Kokkaliaris; Oliver Hilsenbeck; Stavroula Skylaki; Philipp S Hoppe; Axel Schambach; E Richard Stanley; Timm Schroeder
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

2.  Malignancy of eye melanomas originating in the retinal pigment epithelium of transgenic mice after genetic ablation of choroidal melanocytes.

Authors:  B Mintz; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.